Rheumatology treats musculoskeletal and autoimmune diseases, including arthritis, lupus, gout, and vasculitis.
Send us all your questions or requests, and our expert team will assist you.
Sjögren’s syndrome is a long-term autoimmune disease where the immune system attacks the exocrine glands. It was once mainly known for causing dry eyes and dry mouth, but doctors now see it as a more complex condition called “autoimmune epithelitis.” This means the immune system targets the cells lining the salivary and tear glands. Normally, these glands make fluids that keep the mouth and eyes moist. In Sjögren’s, the immune attack damages these glands, leading to a major loss of their ability to produce moisture.
Regenerative medicine sees Sjögren’s syndrome as more than just a problem with the glands; it is a broader issue with the immune system. Both the body’s first-line and specialized immune cells, T-cells and B-cells, move into the glands and form clusters similar to those in lymph nodes. These clusters keep the inflammation going and cause more damage. New research shows that the gland cells themselves also play a role, sending signals that attract more immune cells and worsen the problem.
Regenerative treatments try to change how cells in the glands interact. The goal is to move from ongoing inflammation to a state where healing can happen. Instead of just replacing lost moisture, these new therapies aim to protect what is left of the glands and help repair damaged cells. This is a big change from just treating symptoms to actually trying to fix the disease at the cellular level. By learning what causes the damage, doctors can better target the right parts of the disease process.
Although dry eyes and mouth are the most obvious signs, Sjögren’s syndrome affects the whole body. The same immune attack on the glands can also harm other organs. These problems outside the glands are called “extraglandular manifestations” and show how complex the disease is. Researchers around the world are working to find out what causes this widespread effect and to identify markers that can predict which patients might develop more serious complications.
Cellular research is very important in understanding Sjögren’s syndrome. Scientists are studying the chemical messengers, called cytokines, that drive the disease. One key finding is the “interferon signature,” which means certain genes are turned on by interferon, a protein usually made during viral infections. In Sjögren’s, this pathway stays active even when there is no virus, causing ongoing inflammation. Learning about these processes helps researchers develop new, targeted treatments.
Another important area of research is how Sjögren’s syndrome affects the lymphatic system. People with this disease have a much higher risk of developing B-cell lymphoma than the general population. This is because the disease causes B-cells to be overactive. New treatments are being studied not just to help with dryness, but also to calm the immune system and lower the risk of lymphoma. Managing Sjögren’s well is seen as a way to help prevent these serious complications.
Regenerative medicine for Sjögren’s syndrome focuses on restoring the “niche,” or the local environment that supports stem cells in the glands. In healthy glands, this environment helps keep tissues balanced and able to repair themselves. When inflammation damages this niche, the body’s own repair cells can’t work properly. Treatments using Mesenchymal Stem Cells (MSCs) aim to rebuild a healthy environment so the glands can heal.
MSCs are important because they can help control the immune system. When given through the bloodstream or directly into the glands, they don’t turn into new gland cells right away. Instead, they work by sending out signals that help reduce inflammation and support healing, and by releasing molecules that do the same. These signals calm down overactive immune cells and help the remaining gland cells survive and grow.
This method aligns with the main goal in modern rheumatology: controlling the disease without major side effects from strong immunosuppressant drugs. Regenerative medicine uses the body’s own repair systems, or cells from safe sources, to help control the disease in a more natural way. The aim is to halt the immune attack and provide the glands with what they need to recover. This approach provides patients with a treatment that targets the underlying cause of their symptoms, not just the dryness.
The way patients with Sjögren’s syndrome are cared for has changed a lot. In the past, people often waited a long time for a diagnosis, and their symptoms were sometimes ignored or blamed on aging. Now, care is more proactive and involves a team of specialists, including rheumatologists, eye doctors, dentists, and oral medicine experts. This teamwork is important because the disease can affect many different parts of the body.
Today, early treatment is a top priority. Doctors talk about a “window of opportunity” in Sjögren’s syndrome, meaning that stopping inflammation early, before the glands become scarred, gives the best chance of keeping them working. That’s why patients get a thorough check-up as soon as the disease is suspected. This includes both routine exams and detailed tests to assess how well the glands are functioning.
As care improves, regenerative medicine is now an option for patients who still have problems even after standard treatments. It’s not just a future idea anymore; it’s becoming a real choice for some people. Doctors talk with patients about whether their disease is mostly active inflammation or already caused lasting damage. These details help decide which treatments to use. Adding regenerative medicine to regular care gives new hope to people dealing with severe fatigue and dryness
Send us all your questions or requests, and our expert team will assist you.
The primary cause is an autoimmune reaction where the body’s immune system mistakenly attacks its own healthy cells. Specifically, white blood cells called lymphocytes infiltrate the exocrine glands (mainly salivary and lacrimal glands). This infiltration leads to chronic inflammation and the progressive destruction of the fluid-producing tissues, resulting in the hallmark dryness.
Yes, Sjögren’s syndrome is a systemic autoimmune disease. While the most apparent symptoms affect the eyes and mouth, the inflammation can affect the entire body. It causes systemic symptoms such as profound fatigue and joint pain, and can involve major organs, including the lungs, kidneys, nervous system, and blood vessels.
Traditional treatment primarily focuses on symptom management, such as using artificial tears or saliva substitutes, and broad immune suppression. Regenerative medicine aims to modify the disease process itself by restoring immune balance and promoting the repair of damaged glandular tissue. It uses biological therapies, like stem cells, to create an environment conducive to healing rather than just masking symptoms.
Extraglandular manifestations are symptoms and complications that occur outside the moisture-producing glands. These include arthritis (joint inflammation), peripheral neuropathy (nerve damage), interstitial lung disease, vasculitis (inflammation of blood vessels), and renal (kidney) involvement. These manifestations confirm the systemic nature of the autoimmune dysregulation.
Early diagnosis is crucial because chronic inflammation eventually leads to irreversible fibrosis (scarring) and glandular atrophy. If the disease is identified and treated during the inflammatory phase, before extensive scarring occurs, therapies, especially regenerative ones, have a much better chance of preserving glandular function and preventing permanent disability.
Your Comparison List (you must select at least 2 packages)
